Info@ThinkPinkRocks.com

PALOMA3 supports palbociclib use in advanced breast cancer

Advanced breast cancer patients who have failed prior endocrine treatment may receive a progression-free survival benefit if palbociclib is added to fulvestrant, a phase III trial indicates.

View original post here:
PALOMA3 supports palbociclib use in advanced breast cancer

Share

Leave a Reply